2027 ICD-10-CM Diagnosis Code T46.6X1SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela

ICD-10-CM Codes›S00–T88›T36-T50›T46

ICD-10-CM T46.6X1S
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

T46.6X1S is a billable ICD-10-CM diagnosis code for poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. Coders also document this condition as accidental clofibrate overdose. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T46.6X1S
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
Short Description
Poisn by antihyperlip and antiarterio drugs, acc, sequela
Parent Code
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT46Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
This CodeT46.6X1SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela

Present on Admission (POA)Billing

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Accidental clofibrate overdose
  • Accidental clofibrate poisoning
  • Accidental gamolenic acid overdose
  • Clofibrate overdose
  • Gamolenic acid overdose
  • Lipid-lowering drug overdose
  • Poisoning by clofibrate
  • Statin overdose

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system (T46). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027, published by CMS and the National Center for Health Statistics.

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to T46.6X1S: its own notes plus those printed at T46, block T36-T50, and Chapter 19. A note printed at a category, block or chapter applies to every code under it.

Includes

Further defines, or gives examples of, the content of the category.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • adverse effect of correct substance properly administered
  • poisoning by overdose of substance
  • poisoning by wrong substance given or taken in error
  • underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed

Excludes1

Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.

From T46 Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system applies to 198 codes
  • poisoning by, adverse effect of and underdosing of metaraminol (T44.4)
From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • toxic reaction to local anesthesia in pregnancy (O29.3-)

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • abuse and dependence of psychoactive substances (F10-F19)
  • abuse of non-dependence-producing substances (F55.-)
  • immunodeficiency due to drugs (D84.821)
  • drug reaction and poisoning affecting newborn (P00-P96)
  • pathological drug intoxication (inebriation) (F10-F19)
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes

Code First

The underlying condition named in the note is sequenced before this code.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)

Use Additional Code

Add a second code, after this one, to fully describe the condition.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
  • underdosing of medication regimen (Z91.12-, Z91.13-)
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes
  • code to identify any retained foreign body, if applicable (Z18.-)

Notes

General instructions on how these codes are used.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.

7th Character

Every code in the category takes a 7th character from the listed values, with the placeholder X filling any empty positions before it.

From T46 Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system applies to 198 codes
  • The appropriate 7th character is to be added to each code from category T46
  • Ainitial encounter
  • Dsubsequent encounter
  • Ssequela this code

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient Yes · outpatient Yes

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AcipimoxT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Allyl::disulfideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Aluminium, aluminum::clofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Antiarteriosclerotic drugT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Anticholesterolemic drug NECT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Antihyperlipidemic drugT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Antilipemic drug NECT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BenfluorexT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BenzalbutyramideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Benzyl::nicotinateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
b-benzalbutyramideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
b-sitosterol (s)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BezafibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
BinifibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Cholesterol-lowering agentsT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Cholestyramine (resin)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
CiprofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ClinofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ClofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ClofibrideT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Clotibric acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ColestipolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ColestyramineT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Cyamopsis tetragonolobaT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
DetaxtranT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Ethylparachlorophen-oxyisobutyrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
EtiroxateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
EtofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Etofylline::clofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
FenofibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
GemfibrozilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Guar gum (medicinal)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
HalofenateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Ion exchange resin::cholestyramineT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Linoleic acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Linolenic acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
LovastatinT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
MesoglycanT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Oleic acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
PirozadilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Polidexide (sulfate)T46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
PravastatinT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
ProbucolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
RonifibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Safflower oilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SimfibrateT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SimvastatinT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SitosterolsT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
SoysterolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Sunflower seed oilT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
TriparanolT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6
Unsaturated fatty acidT46.6X1T46.6X2T46.6X3T46.6X4T46.6X5T46.6X6

Patient EducationClinical

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T46.6X1S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.0 Late eff drug poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E929.2 Late eff acc poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About T46.6X1SOverview

Is T46.6X1S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What does the 7th character S in T46.6X1S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional) itself has resolved, not the original event.

What MS-DRG does T46.6X1S group to?

When poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 923, 922, with relative weights from 0.9980 to 1.6248 depending on complications. Higher weights mean higher Medicare reimbursement.

Is T46.6X1S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela on inpatient claims. The code appears in the Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50) range of the CMS exempt list.

Can T46.6X1S be reported with T44.4?

Not as a rule. The Excludes1 note at T46, which applies to T46.6X1S, lists "poisoning by, adverse effect of and underdosing of metaraminol (T44.4)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).